Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
Status:
Unknown status
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
This Ib / IIa clinical trial program focuses on the small cell lung cancer (SCLC), Squamous
non-small cell lung cancer (NSCLC) and adeniform NSCLC in order to start a better development
on the broad-spectrum value of chlorogenic acid： Determine the Disease control rate（DCR）of
phase Ib/IIa of Chlorogenic acid for injection in the advanced Lung Cancer Patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Collaborator:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences